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Introduction
Breast cancer (BC) are fast growing, and frequently insensitive to chemotherapy and radiation therapy [1] . Thus, understanding of the mechanisms underlying the growth of BC is extremely important for its therapy [2] [3] [4] [5] .
Originally cloned from human fetal liver [6] , the Pituitary Tumor Transforming Gene 1 (Pttg1, also known as securin) has been found to increase in an active cell cycle [7] [8] [9] [10] , suggesting a possible role of Pttg1 in the regulation of cell proliferation. The cell cycle Xie/Wang: Pttg1 Promotes Growth of Bc Via P27 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry cellular oxidoreductase enzymes in viable cells reduce the tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to its insoluble formazan in purple readily being quantified by absorbance value (OD) at 570 nm. Experiments were performed three times.
Cell apoptosis assay
Two days after transfection, apoptosis of transfected MCF7 cells was measured using the Annexin V Apoptosis Kit following the manufacturer's instructions (Becton Dickinson Biosciences, San Diego, CA, USA). The cells were stained with fluorescein isothiocyanate-conjugated Annexin V and PI solution (20μg/ mL) for 15 min in the dark. Apoptotic cells (annexin V-positive) were analyzed by flow cytometry.
RNA extraction, reverse transcription and quantitative RT-PCR
Total RNA was extracted from the cultured cells using RNeasy kit (Invitrogen), according to the manufacturer's instruction. For mRNA analysis, complementary DNA (cDNA) was randomly primed from 2μg of total RNA using the Omniscript reverse transcription kit (Qiagen, Hilden, Germany). Real-time PCR was subsequently performed in triplicate with a 1:4 dilution of cDNA using the Quantitect SyBrgreen PCR system (Qiagen). All primers were purchased from Qiagen. Data were collected and analyzed with the Rotorgene software accompanying the PCR machine, using 2-△△Ct method for quantification of the relative mRNA expression levels. Values of genes were first normalized against α-tubulin, and then compared to controls.
Western blot
Total Protein was extracted from the cultured cells by RIPA buffer (Sigma-Aldrich), and nuclear protein was isolated with Nuclear and Cytoplasmic Extraction Kit (Thermo Scientific, St Jose, CA, USA). Equal amount of proteins was loaded in the gel. Primary antibodies for Western Blot are rabbit Pttg1, CDK2, CDK4, CDK6, CyclinB1, CyclinD1, CyclinD2, CyclinE, p21, p27, LaminB1 (nuclear protein loading control) and α-tubulin (total protein loading control) (all purchased from Cell Signaling, St Jose, LA, USA). Secondary antibody is HRP-conjugated anti-rabbit (Jackson ImmunoResearch Labs, West Grove, PA, USA). Images shown in the figure were representative from 5 repeats. Densitometry of Western blots was quantified with NIH ImageJ software.
Immunocytochemistry
Primary antibody is rabbit anti-p27 (Cell Signaling). Indirect fluorescent staining was performed with Cy3-conjugated donkey anti-rabbit secondary antibody (Jackson ImmunoResearch Labs).
Co-immunoprecipitation
The co-immunoprecipitation (IP) procedure was described previously [24] . Briefly, cells were lysed in 5ml of lysis buffer (50mmol/l Tris-HCl, pH 7.5, 200mmol/l NaCl, 0.5% Nonidet P40, protease inhibitor cocktail) for 30 min at 4 °C. Lysates were cleared using centrifugation at 15,000 rpm for 10 min; the supernatant was then subjected to IP with anti-FLAG M2 affinity resin (Sigma-Aldrich) overnight. Resin containing immune complexes were washed with ice cold lysis buffer five times. Proteins were eluted with Flag-peptide (Sigma-Aldrich) in TBS for 30 min. Proteins were precipitated with cold acetone, and the resulting pellet washed two times with cold acetone. IP samples were analyzed by immunoblot (IB).
Statistical analysis
All statistical analyses were carried out using the SPSS 18.0 statistical software package. All values are depicted as mean ± standard deviation and are considered significant if p < 0.05. All data were statistically analyzed using one-way ANOVA with a Bonferoni correction.
Results

Overexpression of Pttg1 was detected in BC specimen
The resected specimens (paired BC tissue and the adjacent normal breast tissue (NBT)) from the 27 BC patients were analyzed for Pttg1 levels by Western blot. We found that Xie/Wang: Pttg1 Promotes Growth of Bc Via P27 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry compared to NBT, BC tissue had a significantly higher Pttg1 levels (Fig. 1, p<0 .05, more than 7-fold increase). These data suggest a role of Pttg1 in the pathogenesis of BC.
Pttg1 increased BC cell proliferation
Then, we aimed to examine whether modification of Pttg1 levels in BC cells may alter cell growth. We used either a Pttg1-overexpressing plasmid, or a plasmid carrying short hairpin small interfering RNA (shRNA) for Pttg1 (shPttg1), to transfect a human BC cell line, MCF7, to increase or decrease Pttg1 levels respectively. MCF7 cells were also transfected with a plasmid carrying a scrambled sequence (scr) as controls. The modifications of Pttg1 levels in MCF7 cells were confirmed by RT-qPCR ( Fig. 2A) , and by Western blot (Fig. 2B) . We found that overexpression of Pttg1 in MCF7 cells (MCF7-Pttg1) significantly increased cell growth in an MTT assay (Fig. 2C) , while depletion of Pttg1 in MCF7 cells (MCF7-shPttg1) significantly decreased cell growth (Fig. 2C) . To figure out whether the effects of Pttg1 on cell growth are contributable to alterations in cell proliferation or cell apoptosis, we examined cell apoptosis in these Pttg1-modified MCF7 cells. We found that the changes in Pttg1 levels in MCF7 cells did not significantly alter the apoptosis of the cells (Fig. 2D) , suggesting that the effects of Pttg1 on cell growth are contributable to alterations in cell proliferation, rather than the alterations in cell apoptosis. In another word, Pttg1 increased BC cell proliferation.
Pttg1 decreased nuclear p27 levels to increase BC cell proliferation
We next aimed to find out the molecular mechanisms underlying the Pttg1-induced BC cell growth. We examined the levels of all CDKs, Cyclins and cell-cycle inhibitors that had been shown to be involved in the pathogenesis of BC in these Pttg1-modified MCF7 cells by Western blot. Since only nuclear forms of these proteins are critical for the regulation of cell-cycle-associated genes, while cytosol forms are not, we isolated nuclear proteins to analyze. We did not find changes in CDKs, Cyclins and p21 in these Pttg1-modified BC cells, but detected a significant increase in p27 in Pttg1-deprived cells and a significant decrease in p27 in Pttg1-overexpressing cells (Fig. 3A) . Immunocytochemistry confirmed this finding, suggesting that the nuclear exclusion of p27 may be induced by Pttg1 (Fig. 3B) . Together, these data suggest that Pttg1 may prevent nuclear retention of p27 and induce its nuclear exclusion to allow cells to proliferate.
Pttg1 directly binds to p27
To find out whether the effects of Pttg1 on p27 are direct or indirect, we performed co-immunoprecipitation (IP) to detect the physical interaction between Pttg1 and p27. Our results showed that endogenous Pttg1 co-precipitated with p27 and vice versa in MCF7 cells Fig. 1 . Overexpression of Pttg1 is detected in BC specimen. The resected specimens (paired BC tissue and the adjacent normal breast tissue (NBT)) from the 27 BC patients were analyzed for Pttg1 levels by Western blot. We found that compared to NBT, BC tissue had a significantly higher Pttg1 levels (Fig. 1,  p<0 .05, more than 7-fold increase). *p<0.05. n=27. Statistics: one-way ANOVA with a Bonferoni correction. Fig. 2 . Pttg1 increases BC cell proliferation. We used either a Pttg1-overexpressing plasmid, or a plasmid carrying short hairpin small interfering RNA (shRNA) for Pttg1 (shPttg1), to transfect a human BC cell line, MCF7, to increase or decrease Pttg1 levels respectively. MCF7 cells were also transfected with a plasmid carrying a scrambled sequence (scr) as controls. (A-B) The modifications of Pttg1 levels in MCF7 cells were confirmed by RT-qPCR (A), and by Western blot (B). (C) We found that overexpression of Pttg1 in MCF7 cells (MCF7-Pttg1) significantly increased cell growth in an MTT assay, while depletion of Pttg1 in MCF7 cells (MCF7-shPttg1) significantly decreased cell growth. (D) We examined cell apoptosis in these Pttg1-modified MCF7 cells and found that the changes in Pttg1 levels in MCF7 cells did not significantly alter the apoptosis of the cells. *p<0.05. NS: non-significant. n=5. Statistics: one-way ANOVA with a Bonferoni correction. Fig. 3 . Pttg1 decreases nuclear p27 levels to increase BC cell proliferation. (A) We examined the nuclear protein levels of all CDKs, Cyclins and cell-cycle inhibitors that had been shown to be involved in the pathogenesis of BC in these Pttg1-modified MCF7 cells by Western blot. We did not find changes in any CDKs, Cyclins and p21 in these Pttg1-modified PC cells, but detected a significant increase in p27 in Pttg1-deprived cells and a significant decrease in p27 in Pttg1-overexpressing cells. (B) Immunocytochemistry for p27 in Pttg1-modified MCF7 cells. (Fig. 4) . These data suggest that Pttg1 and p27 physically associate with each other in BC cells. Thus, Pttg1 may directly bind to p27, which induces nuclear exclusion of p27 to allow the cells to growth (Fig. 5) .
Discussion
The molecular mechanisms that underlies the regulation of cancer growth by Pttg1 in BC are far from clarified. A recent study has shown that the key downstream component of TGFβ receptor signaling pathway SMAD3 is regulated by Pttg1 in a prostate cell line [23] . Activated by TGFβ receptor signaling pathway, SMAD3 is phosphorylated and then forms heteromeric complexes with SMAD4 to translocate to the nucleus to inhibit cell proliferation [23] . Together with our findings here, it appeared that the roles of Pttg1 on cell growth of cancer cells are cancer-cell-type independent.
In the present study, we used BC cell line MCF7, and reproduced the effects of Pttg1 on cell proliferation. Moreover, we found out that p27, a cell-cycle inhibitor, was directly associated with Pttg1, which affected the nuclear localization of p27. Of note, p27 is also directly regulated by TGFβ receptor signaling pathway [15] [16] [17] [18] [19] [20] [21] [22] . Therefore, our study suggests that the findings in the previous study of Pttg1/SMAD3 on cell proliferation may be transduced through their downstream target p27, although this cascade has not been examined in the previous study [23] . Moreover, since we detected a direct association of p27 with Pttg1, the effects of Pttg1 on cell proliferation may transduce indirectly via SMAD3/p27 signaling, and directly via p27. We have checked several other lines and got essentially same results. 5 . Schematic of the model. Pttg1 may directly bind to p27, which induces nuclear exclusion of p27 to allow the BC cells to grow.
